Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:923190.
doi: 10.1155/2012/923190. Epub 2012 Mar 18.

Comparison of a Chinese Herbal Medicine (CCH1) and Lactulose as First-Line Treatment of Constipation in Long-Term Care: A Randomized, Double-Blind, Double-Dummy, and Placebo-Controlled Trial

Chien-Hsun Huang  1 , Jui-Shan Lin, Tsai-Chung Li, Shih-Chang Lee, Hsiu Po Wang, Hung-Chi Lue, Yi-Chang Su
Affiliations

Comparison of a Chinese Herbal Medicine (CCH1) and Lactulose as First-Line Treatment of Constipation in Long-Term Care: A Randomized, Double-Blind, Double-Dummy, and Placebo-Controlled Trial

Chien-Hsun Huang et al. Evid Based Complement Alternat Med. 2012.

Abstract

Many institutionalized patients and their healthcare providers are dissatisfied with current laxative therapy. This study compared therapeutic efficacy, safety, and laxative cost of an herbal formula (CCH1) and lactulose for long stay patients with constipation. In this double-blind, double-dummy, and placebo-controlled trial, we randomized 93 residents with chronic constipation from two long-term care facilities in Taiwan to receive either CCH1 with lactulose placebo or CCH1 placebo with lactulose for 8 weeks, then followed up for 4 weeks without study medication. Both treatments were effective and well tolerated for patients, but CCH1 produced more spontaneous bowel movements, less rectal treatments, less amount of rescue laxative, and lower laxative cost than lactulose during treatment. No significant differences were found in stool consistency, stool amount, global assessment, and safety concerns. In conclusion, our results suggest that CCH1 may have better efficacy and could be used as an alternative option to lactulose in the treatment of constipation in long-term care.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Participant flowchart depicting the randomization, treatment, and followup in CCH1 and lactulose groups.
See this image and copyright information in PMC

References

    1. Tariq SH. Constipation in long-term care. Journal of the American Medical Directors Association. 2007;8(4):209–218. - PubMed
    1. Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. Bowel habit in relation to age and gender. Findings from the national health interview survey and clinical implications. Archives of Internal Medicine. 1996;156(3):315–320. - PubMed
    1. Phillips C, Polakoff D, Maue SK, Mauch R. Assessment of constipation management in long-term care patients. Journal of the American Medical Directors Association. 2001;2(4):149–154. - PubMed
    1. Bouras EP, Tangalos EG. Chronic constipation in the elderly. Gastroenterology Clinics of North America. 2009;38(3):463–480. - PubMed
    1. Dennison C, Prasad M, Lloyd A, Bhattacharyya SK, Dhawan R, Coyne K. The health-related quality of life and economic burden of constipation. PharmacoEconomics. 2005;23(5):461–476. - PubMed

LinkOut - more resources